Over the years, several minimally invasive surgical treatments (MISTs) have been proposed as alternative therapies for benign prostate hyperplasia (BPH) to allow a significant improvement in lower urinary tract symptoms (LUTS) and a reduction in hospital stay and postoperative complications compared to traditional surgery.